Canadian Cancer Trial Groups (CCTG)

 
Activated protocol list

 

BR.38 -

A RANDOMIZED PHASE 3 TRIAL FOR CONSOLIDATIVE USE OF RADIOTHERAPY TO BLOCK (CURB2) OLIGOPROGRESSION IN PATIENTS WITH METASTATIC NON-SMALL-CELL LUNG CANCER

CE.7 -

A Phase III Trial of Stereotactic Radiosurgery Compared with Whole Brain Radiotherapy (WBRT) for 5-15 Brain Metastases

CO.32 -

A PHASE 3 RANDOMIZED TRIAL OF NEOADJUVANT CHEMOTHERAPY, EXCISION AND OBSERVATION VERSUS CHEMORADIOTHERAPY FOR EARLY RECTAL CANCER

HN.11 -

SPECT-CT GUIDED ELECTIVE CONTRALATERAL NECK TREATMENT (SELECT) FOR PATIENTS WITH LATERALIZED OROPHARYNGEAL CANCER: A PHASE III RANDOMIZED CONTROLLED TRIAL

MA.39 -

TAILOR RT: A RANDOMIZED TRIAL OF REGIONAL RADIOTHERAPY IN BIOMARKER LOW RISK NODE POSITIVE BREAST CANCER

PR.24 -

ANDROGEN SUPPRESSION COMBINED WITH ELECTIVE NODAL IRRADIATION AND DOSE ESCALATED PROSTATE TREATMENT: A NON-INFERIORITY, PHASE III RANDOMIZED CONTROLLED TRIAL OF STEREOTACTIC BODY RADIATION THERAPY VERSUS BRACHYTHERAPY BOOST IN PATIENTS WITH UNFAVOURABLE RISK LOCALIZED PROSTATE CANCER (ASCENDE-SBRT)

CCTG MA.39

 

This protocol is a randomization between two Arms and under each arm there are two Groups. Each institution must complete the credentialing process before a patient can be placed on the protocol. Once the institution has met the minimum requirements for credentialing, IROC-Houston will send a letter to the Radiation Oncologist, Physicist, Dosimetrist and data manager, as specified on the DDSI, stating that their institution has successfully completed the credentialing process, for a specific modality, and can begin placing patients on the study.

This protocol requires each institution to submit electronic patient data to TRIAD. For instructions on TRIAD, click here.

All Institutions must complete the following:

Credentialing Status Inquiry Form:

Please fill out the credentialing status inquiry form to let us know that you would like to be credentialed for this protocol. Institutions that are credentialed for NSABP B51/RTOG 1304 need only update their Facility Questionnaire and complete the credentialing status inquiry form.

Facility Questionnaire:

Update the electronic IROC Houston Facility Questionnaire. A password protected link has been supplied to the institution’s primary clinical trial physicist or can be obtained by contacting the IROC Houston at IROCHouston@mdanderson.org

Benchmark Cases:

All the Benchmark cases, and study patient cases on this trial need to be submitted digitally to TRIAD. Please submit for the initial and boost (if applicable) plans the DICOM planning CT, RTplan, RTdose and RTstructure files.

This study requires each institution to complete a benchmark case for Arm 2/Group 2A. The institution may decide which modality 3DCRT and/or IMRT they wanted to be credentialed for.

If a site would like to be credentialed for 3D only then Arm 2/Group 2A benchmark will be done using 3D CRT. If a site would like to be credentialed for IMRT only, then the Arm 2/Group 2A benchmark needs to be done using IMRT.

If an institution wishes to be credentialed for both modalities, 3D CRT & IMRT, then two Arm 2/Group 2A benchmark cases will need to be submitted, one must be planned using IMRT and the other using 3DCRT.

If a site is credentialed for 3D CRT only, and wishes to be credentialed for IMRT, then the site needs to submit a Benchmark case for Arm 2/Group 2A that is planned with IMRT, and vice versa for IMRT.

Arm 2 Group 2A  Benchmark (Lumpectomy: Regional nodal XRT with WBI)

Please complete the Dosimetry Summary Form (For each patient / Benchmark)

Download  Nodal Contouring Atlas  

Phantom Irradiation:

If credentialing for IMRT, an irradiation of the IROC Houston's IMRT H&N phantom is required (see note below). Please fill in the request form online

Note: Institutions that are credentialed to participate in other IMRT protocols requiring an IMRT H&N phantom irradiation need not repeat the phantom irradiation for credentialing for this protocol.

Please note regarding Pre-Treatment and On-Treatment Reviews:

Pre-Treatment Reviews are required for the first 2 cases treated on Arm1/Group1A and for the first 3 cases treated on Arm 2/Group 2A or 2B (At least one case of each from Groups 2A & 2B should be submitted). Please submit pre-treatment reviews at least 7 business days prior to treatment start date, allowing 3 business days for the review to be completed once all data is received by IROC Houston.

On-Treatment Reviews must be submitted within 21 days of treatment initiation. Cases will be reviewed and feedback will be provided back to the submitting radiation oncologist.

All data must be submitted via TRIAD. The following data must be submitted for each patient:

  1. Planning CT in DICOM format
  2. DICOM RT structure set
  3. DICOM RT plan file
  4. DICOM RT dose file
  5. Completed DDSI
  6. Dosimetry Summary Form
  7. Radiotherapy Review Submission Form

 

CCTG CE.7

 

This protocol requires each institution to submit electronic patient data to TRIAD. For instructions on TRIAD, click here.

Please fill out the  Credentialing Status Inquiry Form to let us know that you would like to be credentialed for this protocol.

Institutions that were previously credentialed to participate in another protocol will be notified if any additional credentialing steps are required.

SRS credentialing is required for all sites.

In order to complete the SRS credentialing process, the following items must be completed:

• All participants are asked to update an existing or complete a new Facility Questionnaire

• Irradiate IROC Houston's SRS head phantom. Please fill out the request form online

 

 In order to be credentialed for HA-WBRT, please complete the following:

• Each treating physician must download and complete  benchmark case and submit to TRIAD. Sites are to generate an IMRT plan for WBRT with hippocampal avoidance as per protocol criteria.

Note:Clinicians who are credentialed for CC001 and CC003 do not need to repeat the HA credentialing step

• 1). Both CT data sets (CT and MRI ) were included in the Benchmark, and can be uploaded into TPS at the same time.GTV represents enhancing mets that are within 5 mm of the hippocampi.The GTV contour is not required for the credentialing benchmark case.

• 2). Institutions will be credentialed for either IMRT or VMAT depending on how the benchmark plan was created. If an institution wants to be credentialed for IMRT and VMAT then two benchmark submissions are required; one IMRT and one VMAT)

CCTG HN.11

 

Please fill out the  Credentialing Status Inquiry Form to let us know that you would like to be credentialed for this protocol.

This protocol requires each institution to submit electronic patient data to TRIAD. For instructions on TRIAD, click  here.

For this study, IMRT and IGRT are required.

In order to complete the IMRT credentialing process, the following items must be completed:

• All participants are required to complete the Facility Questionnaire

• All participants must complete IGRT credentialing for bony alignment. Please also complete the   online

• Irradiate the IROC Houston's H&N phantom. Please fill in the  request form online

 

 Note:

• Institutions that have been previously credentialed to deliver IMRT, IGRT, and/or VMAT through active participation in CCTG HN.6, CCTG HN.9, CCTG HN.10, EORTC 1219, NRG HN001, HN002, HN004, or HN005, they will not be required to complete the IMRT phantom study for HN.11. To determine whether your institution needs to complete any further credentialing requirements, please complete the  Credentialing Status Inquiry.

CCTG BR.38

 

Please fill out the  Credentialing Status Inquiry Form to let us know that you would like to be credentialed for this protocol.

This protocol requires each institution to submit electronic patient data to TRIAD. For instructions on TRIAD, click here.

In order to complete the IMRT credentialing process, the following items must be completed:

• All participants are required to complete the Facility Questionnaire

• Irradiate the IROC Houston's H&N phantom. Please fill in the  request form online

• All participants must complete IGRT credentialing for Soft Tissue alignment. Please also complete the IGRT questionnaire online.

In order to complete the Proton credentialing process, the following items must be completed:

• All participants must have completed baseline approval for proton therapy.

• All participants are asked to complete the Facility Questionnaire.

• Successfully complete the Soft Tissue IGRT credentialing requirements. Please also complete the IGRT questionnaire.

• Irradiate the IROC Houston's proton H & N phantom. Please fill in the request form online.

Note:

Institutions that are credentialed to participate in other IMRT protocols requiring an IMRT H&N phantom irradiation might not need to repeat the phantom irradiation for credentialing for this protocol. To determine whether your institution needs to complete any further credentialing requirements, please complete the  Credentialing Status Inquiry Form.

CCTG CO.32

 

Please fill out the  Credentialing Status Inquiry Form to let us know that you would like to be credentialed for this protocol.

To be credentialed for IMRT technique, the following items must be completed:

• All participants are required to complete the Facility Questionnaire

• Irradiate the IROC Houston's H&N phantom. Please fill in the  request form online

Patient Data Submission:

•  RT treatment plans in DICOM format, including treatment planning MRI/CT dataset, RT structure file, RT dose file(s), and plan file (s) must be submitted to TRIAD. For instructions on TRIAD, click  here

•  Digital Data Submission Information (DDSI) Form. Here is the link for DDSI form https://www.irocqa.org/Resources/DDSI-Form

 Note:

Institutions that are credentialed to participate in other IMRT protocols requiring an IMRT H&N phantom irradiation might not need to repeat the phantom irradiation for credentialing for this protocol. To determine whether your institution needs to complete any further credentialing requirements, please complete the  Credentialing Status Inquiry.

CCTG PR.24

 

This trial will utilize TRIAD for dosimetry digital treatment data submission. TRIAD is the American College of Radiology’s (ACR) image exchange application and it is used by the NRG. See here for information on installing TRIAD.

Please fill out the credentialing status inquiry  form to let us know that you would like to be credentialed for this protocol. To be credentialed for 3D, IMRT & SBRT technique, the following items must be completed:

• All participants are required to complete the Facility Questionnaire

•  Irradiate the IROC Houston's H&N phantom. Please fill in the request form online.

•  Successfully complete the soft tissue IGRT requirements. Please also complete the IGRT questionnaire.

Note:

Institutions that are credentialed to participate in other IMRT protocols requiring an IMRT H&N phantom irradiation might not need to repeat the phantom irradiation for credentialing for this protocol. Institutions that are credentialed to participate in other soft tissue IGRT protocols might not need to repeat IGRT credentialing for this protocol. To determine whether your institution needs to complete any further credentialing requirements, please complete the Credentialing Status Inquiry.

LDR Brachytherapy Credentialing :

Institutions wishing to enter patients onto protocols that include permanent prostate brachytherapy implants must be credentialed prior to participation in the study. Because these procedures require a team effort, the institution, the radiation oncologist and radiation physicist are credentialed as a team.

  1. LDR Facility Questionnaire.
  2. Reference Case.
  3. Submit post implant data for a recent LDRReference Case. prostate patient to be submitted digitally to TRIAD .
  4. If performing TRUS-based planning, please complete the TRUS Questionnaire .

LDR Facility Questionnaire and Reference Case 1 can be emailed to jlowenst@mdanderson.org or submitted via snail mail to:

Attention: Dosimetry
IROC Houston QA Center
8060 El Rio St.
Houston, TX 77054

Note:

An institution that has been previously credentialed for a radiation source model does not need to submit the complete package to become credentialed for an additional source model. It is only necessary to submit the reference case, performed with the new source model. Similarly, changing to a different treatment planning system requires re-credentialing, and only the two reference cases need to be submitted. However, change in physician requires a submission of an updated LDR Facility Questionnaire and a recently treated LDR prostate patient.

  1. Common Errors Found in Low Dose Rate (LDR) Prostate Credentialing - ASTRO 2013 Poster.
  2. Sample of a satisfactory Dry-run Case.

HDR Brachytherapy Credentialing :

Institutions wishing to enter patients onto protocols that include HDR prostate brachytherapy implants must be credentialed prior to participation in the study. Because these procedures require a team effort, the institution, the radiation oncologist and radiation physicist are credentialed as a team.

  1. HDR Prostate Facility Questionnaire (including the benchmark case).Please emailed to jlowenst@mdanderson.org
  2. Submit post implant data for a recent HDR prostate patient to be submitted digitally to TRIAD .
  3. If performing TRUS-based planning, please complete the TRUS Questionnaire .

Note:

Institutions previously credentialed for prostate brachytherapy are eligible to participate on this protocol using HDR if there has not been a change in physician or physicist. Please complete the credentialing status inquiry form if you were credentialed previously for a prostate LDR or HDR trial (i.e. 0815, 1115, 0924, GU009, or GU010). We will notify you if any additional credentialing is required.